Shattuck Accounts Payable vs Deferred Long Term Liab Analysis

STTK Stock

USD 1.09 0.01 0.93%

Shattuck Labs financial indicator trend analysis is much more than just breaking down Shattuck Labs prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shattuck Labs is a good investment. Please check the relationship between Shattuck Labs Accounts Payable and its Deferred Long Term Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.

Accounts Payable vs Deferred Long Term Liab

Accounts Payable vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shattuck Labs Accounts Payable account and Deferred Long Term Liab. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Shattuck Labs' Accounts Payable and Deferred Long Term Liab is 0.57. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Shattuck Labs, assuming nothing else is changed. The correlation between historical values of Shattuck Labs' Accounts Payable and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Shattuck Labs are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Accounts Payable i.e., Shattuck Labs' Accounts Payable and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.57

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Shattuck Labs obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Shattuck Labs are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Shattuck Labs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shattuck Labs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.The value of Selling General Administrative is expected to slide to about 14.3 M. The value of Issuance Of Capital Stock is estimated to slide to about 45.8 M

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.4M	3.1M	4.0M	4.2M
Interest Income	625K	1.6M	4.7M	4.9M

Depreciation And Amortization Interest Income

Shattuck Labs fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.81	-0.13	0.99	0.02	0.97	0.53	-0.77	-0.86	-0.55	0.49	0.87	0.51	0.45	0.53	1.0	0.88	0.75	0.82	-0.83	0.89	0.88	-0.81	0.99	0.47	1.0
Other Current Liab	0.81		0.03	0.86	-0.48	0.86	0.9	-0.94	-0.6	-0.78	0.72	0.61	0.89	0.77	0.53	0.75	0.92	0.82	0.63	-0.95	0.91	0.92	-0.9	0.86	0.74	0.78
Total Current Liabilities	-0.13	0.03		-0.17	-0.06	-0.25	-0.09	0.25	0.59	0.5	0.61	-0.56	-0.11	-0.34	0.39	-0.14	-0.31	-0.29	0.35	0.26	0.15	-0.3	0.39	-0.17	-0.45	-0.13
Total Stockholder Equity	0.99	0.86	-0.17		-0.06	0.99	0.61	-0.83	-0.87	-0.63	0.51	0.88	0.6	0.52	0.53	0.98	0.93	0.79	0.79	-0.88	0.9	0.93	-0.86	1.0	0.55	0.99
Other Liab	0.02	-0.48	-0.06	-0.06		-0.1	-0.69	0.54	-0.05	0.61	-0.44	0.1	-0.68	-0.61	-0.32	0.1	-0.29	-0.25	0.24	0.48	-0.34	-0.31	0.46	-0.06	-0.7	0.07
Net Tangible Assets	0.97	0.86	-0.25	0.99	-0.1		0.65	-0.86	-0.9	-0.68	0.47	0.91	0.64	0.57	0.5	0.96	0.96	0.81	0.74	-0.91	0.88	0.96	-0.89	0.99	0.6	0.96
Property Plant And Equipment Net	0.53	0.9	-0.09	0.61	-0.69	0.65		-0.89	-0.43	-0.87	0.56	0.43	1.0	0.91	0.28	0.44	0.82	0.71	0.28	-0.87	0.67	0.83	-0.84	0.61	0.87	0.48
Current Deferred Revenue	-0.77	-0.94	0.25	-0.83	0.54	-0.86	-0.89		0.7	0.92	-0.54	-0.68	-0.88	-0.84	-0.44	-0.72	-0.94	-0.9	-0.44	0.99	-0.83	-0.93	0.98	-0.83	-0.88	-0.74
Net Debt	-0.86	-0.6	0.59	-0.87	-0.05	-0.9	-0.43	0.7		0.65	-0.07	-0.98	-0.42	-0.49	-0.25	-0.87	-0.83	-0.66	-0.48	0.78	-0.64	-0.84	0.82	-0.87	-0.57	-0.86
Retained Earnings	-0.55	-0.78	0.5	-0.63	0.61	-0.68	-0.87	0.92	0.65		-0.22	-0.6	-0.88	-0.95	-0.12	-0.49	-0.82	-0.77	-0.08	0.9	-0.57	-0.83	0.93	-0.63	-0.99	-0.51
Accounts Payable	0.49	0.72	0.61	0.51	-0.44	0.47	0.56	-0.54	-0.07	-0.22		0.11	0.52	0.22	0.84	0.44	0.47	0.46	0.69	-0.51	0.79	0.47	-0.4	0.51	0.22	0.47
Cash	0.87	0.61	-0.56	0.88	0.1	0.91	0.43	-0.68	-0.98	-0.6	0.11		0.44	0.44	0.27	0.87	0.85	0.65	0.54	-0.75	0.64	0.85	-0.79	0.88	0.51	0.87
Non Current Assets Total	0.51	0.89	-0.11	0.6	-0.68	0.64	1.0	-0.88	-0.42	-0.88	0.52	0.44		0.92	0.24	0.43	0.82	0.7	0.26	-0.86	0.64	0.82	-0.83	0.6	0.87	0.47
Non Currrent Assets Other	0.45	0.77	-0.34	0.52	-0.61	0.57	0.91	-0.84	-0.49	-0.95	0.22	0.44	0.92		-0.04	0.37	0.74	0.68	0.04	-0.82	0.47	0.75	-0.84	0.52	0.95	0.4
Other Assets	0.53	0.53	0.39	0.53	-0.32	0.5	0.28	-0.44	-0.25	-0.12	0.84	0.27	0.24	-0.04		0.52	0.41	0.35	0.65	-0.45	0.78	0.41	-0.37	0.53	0.11	0.53
Cash And Short Term Investments	1.0	0.75	-0.14	0.98	0.1	0.96	0.44	-0.72	-0.87	-0.49	0.44	0.87	0.43	0.37	0.52		0.83	0.71	0.83	-0.78	0.86	0.84	-0.76	0.98	0.4	1.0
Common Stock Total Equity	0.88	0.92	-0.31	0.93	-0.29	0.96	0.82	-0.94	-0.83	-0.82	0.47	0.85	0.82	0.74	0.41	0.83		0.85	0.59	-0.96	0.83	1.0	-0.95	0.93	0.76	0.85
Common Stock Shares Outstanding	0.75	0.82	-0.29	0.79	-0.25	0.81	0.71	-0.9	-0.66	-0.77	0.46	0.65	0.7	0.68	0.35	0.71	0.85		0.5	-0.85	0.72	0.83	-0.85	0.79	0.69	0.73
Short Term Investments	0.82	0.63	0.35	0.79	0.24	0.74	0.28	-0.44	-0.48	-0.08	0.69	0.54	0.26	0.04	0.65	0.83	0.59	0.5		-0.49	0.79	0.58	-0.41	0.79	-0.01	0.83
Non Current Liabilities Total	-0.83	-0.95	0.26	-0.88	0.48	-0.91	-0.87	0.99	0.78	0.9	-0.51	-0.75	-0.86	-0.82	-0.45	-0.78	-0.96	-0.85	-0.49		-0.86	-0.97	0.99	-0.88	-0.86	-0.8
Other Current Assets	0.89	0.91	0.15	0.9	-0.34	0.88	0.67	-0.83	-0.64	-0.57	0.79	0.64	0.64	0.47	0.78	0.86	0.83	0.72	0.79	-0.86		0.84	-0.8	0.9	0.53	0.88
Other Stockholder Equity	0.88	0.92	-0.3	0.93	-0.31	0.96	0.83	-0.93	-0.84	-0.83	0.47	0.85	0.82	0.75	0.41	0.84	1.0	0.83	0.58	-0.97	0.84		-0.96	0.93	0.77	0.86
Total Liab	-0.81	-0.9	0.39	-0.86	0.46	-0.89	-0.84	0.98	0.82	0.93	-0.4	-0.79	-0.83	-0.84	-0.37	-0.76	-0.95	-0.85	-0.41	0.99	-0.8	-0.96		-0.86	-0.89	-0.78
Net Invested Capital	0.99	0.86	-0.17	1.0	-0.06	0.99	0.61	-0.83	-0.87	-0.63	0.51	0.88	0.6	0.52	0.53	0.98	0.93	0.79	0.79	-0.88	0.9	0.93	-0.86		0.55	0.99
Property Plant And Equipment Gross	0.47	0.74	-0.45	0.55	-0.7	0.6	0.87	-0.88	-0.57	-0.99	0.22	0.51	0.87	0.95	0.11	0.4	0.76	0.69	-0.01	-0.86	0.53	0.77	-0.89	0.55		0.43
Total Current Assets	1.0	0.78	-0.13	0.99	0.07	0.96	0.48	-0.74	-0.86	-0.51	0.47	0.87	0.47	0.4	0.53	1.0	0.85	0.73	0.83	-0.8	0.88	0.86	-0.78	0.99	0.43

Click cells to compare fundamentals

Shattuck Labs Account Relationship Matchups

Shattuck Labs fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	45.0M	349.0M	298.6M	205.3M	159.6M	206.4M
Other Current Liab	425K	7.4M	14.6M	17.1M	9.1M	8.9M
Total Current Liabilities	20.0M	16.8M	24.6M	25.0M	11.5M	15.8M
Total Stockholder Equity	(34.5M)	309.9M	271.8M	176.2M	144.7M	157.1M
Net Tangible Assets	(34.5M)	309.9M	271.8M	176.2M	202.6M	156.7M
Property Plant And Equipment Net	2.4M	3M	9.9M	17.7M	13.8M	9.0M
Net Debt	(7.0M)	(157.9M)	(92.3M)	(43.2M)	(121.4M)	(115.4M)
Retained Earnings	(35.5M)	(72.1M)	(117.1M)	(219.0M)	(306.3M)	(291.0M)
Accounts Payable	3.1M	1.8M	10.0M	7.2M	1.6M	1.5M
Cash	7.0M	157.9M	92.3M	47.4M	125.6M	84.7M
Non Currrent Assets Other	90K	349K	381K	3.1M	2.5M	2.7M
Other Assets	90K	349K	10.3M	434K	1.0	0.95
Cash And Short Term Investments	39.1M	335.4M	268.8M	161.3M	130.6M	182.5M
Common Stock Shares Outstanding	41.7M	41.8M	42.0M	42.4M	42.6M	41.4M
Short Term Investments	32.1M	177.6M	176.5M	113.9M	5.0M	4.7M
Liabilities And Stockholders Equity	45.0M	349.0M	298.6M	205.3M	159.6M	206.4M
Non Current Liabilities Total	59.5M	22.3M	2.2M	4.2M	3.4M	3.2M
Other Current Assets	3.4M	20.4M	38.9M	23.3M	12.6M	19.0M
Other Stockholder Equity	(48.2M)	382.0M	389.4M	396.0M	451.0M	288.0M
Total Liab	79.5M	39.1M	26.8M	29.2M	14.9M	14.1M
Net Invested Capital	(34.5M)	309.9M	271.8M	176.2M	144.7M	157.1M
Property Plant And Equipment Gross	2.4M	3M	9.9M	17.7M	23.3M	24.5M
Total Current Assets	42.4M	345.6M	288.3M	184.6M	143.2M	196.1M
Accumulated Other Comprehensive Income	54K	(63K)	(560K)	(877K)	4K	4.2K
Net Working Capital	22.5M	328.8M	263.7M	159.6M	131.8M	174.4M
Property Plant Equipment	2.4M	3M	9.9M	17.7M	20.3M	21.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Shattuck Labs is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Shattuck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Shattuck Labs Stock. Highlighted below are key reports to facilitate an investment decision about Shattuck Labs Stock:

How To Invest In Shattuck

Details

Is Shattuck Stock a good investment?

Details

What is Shattuck Labs' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shattuck Labs. If investors know Shattuck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shattuck Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.53)

Revenue Per Share

0.088

Quarterly Revenue Growth

7.045

Return On Assets

(0.40)

Return On Equity

(0.68)

The market value of Shattuck Labs is measured differently than its book value, which is the value of Shattuck that is recorded on the company's balance sheet. Investors also form their own opinion of Shattuck Labs' value that differs from its market value or its book value, called intrinsic value, which is Shattuck Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shattuck Labs' market value can be influenced by many factors that don't directly affect Shattuck Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Shattuck Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shattuck Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shattuck Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shattuck Accounts Payable vs Deferred Long Term Liab Analysis

Accounts Payable vs Deferred Long Term Liab

Accounts Payable vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Accounts Payable

Deferred Long Term Liab

Shattuck Labs fundamental ratios Correlations

Shattuck Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shattuck Labs fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Stockholder Equity	+ 1.0	Common Stock Total Equity

Property Plant And Equipment Gross	- 0.99	Retained Earnings
Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.97	Non Current Liabilities Total
Total Liab	- 0.96	Other Stockholder Equity
Non Current Liabilities Total	- 0.96	Common Stock Total Equity
Total Liab	- 0.95	Common Stock Total Equity